Thus, our results indicate that augmented YAP signaling underlies many of the musculoskeletal defects seen upon loss of MyHC‐embryonic function and might be an important potential pathway to target in patients with SCTS and other MYH3‐related congenital syndromes. The gene discussed is MYH3; the disease is Scott syndrome.